<DOC>
	<DOCNO>NCT00017628</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine efficacy , term disease progression , high-dose cyclophosphamide total body irradiation T lymphocyte-depleted autologous peripheral blood stem cell bone marrow rescue patient multiple sclerosis .</brief_summary>
	<brief_title>Phase I Study High-Dose Cyclophosphamide Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell Bone Marrow Rescue Patients With Multiple Sclerosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Following induction course cyclophosphamide IV , patient receive filgrastim ( G-CSF ) subcutaneously ( SC ) daily completion peripheral blood stem cell ( PBSC ) harvesting . PBSCs collect several day . Patients mobilize sufficient cell undergo bone marrow harvest . Harvested PBSCs bone marrow undergo T-lymphocyte depletion . Patients receive cyclophosphamide IV 1 hour day -6 -5 methylprednisolone IV daily day -4 -1 . Patients also undergo total body irradiation twice day day -4 -1 . Lymphocyte-depleted PBSCs bone marrow reinfused day 0 . Patients receive G-CSF SC daily begin day 0 continue blood count recover 3 day . Patients follow 1 , 2 , 3 , 6 , 12 month annually 5 year .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis multiple sclerosis Kurtzke score 4.07.5 Increase 1.0 point past 12 month More 3 relapse 24 month despite conventional disease modify therapy Failure stabilize active clinical progression 3day regimen methylprednisolone IV Prior/Concurrent Therapy Chemotherapy : No prior cladribine Radiotherapy : No prior radiotherapy great 10 cm2 lung tissue No prior craniospinal irradiation No prior total lymphoid irradiation Patient Characteristics Hematopoietic : Absolute neutrophil count least 1,000/mm3 Platelet count least 100,000/mm3 Hemoglobin least 9.0 g/dL Hepatic : Hepatitis B antigen negative Bilirubin great 2.0 mg/dL Transaminases great 2 time upper limit normal Renal : Creatinine great 2.0 mg/dL Cardiovascular : No history coronary artery disease Resting LVEF least 45 % Pulmonary : FEV1/FVC least 75 % predict DLCO least 50 % predict Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception HIV negative No uncontrolled diabetes mellitus No concurrent medical illness would preclude study No concurrent psychiatric illness mental deficiency would preclude study No prior malignancy except localize basal cell squamous cell skin cancer ( malignancy judge cured local surgical therapy head neck cancer stage I breast cancer , consider individual basis ) No presence body shrapnel , metal fragment , unremovable device pacemaker aneurysm clip</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>